Buprenorphine-Waivered Providers — County Data

Return to the Report

Geographic Disparities Affect Access to Buprenorphine Services for Opioid Use Disorder, OEI-12-17-00240

Share this Map

By selecting different views in the map below, users can see by county:

• The availability of office-based buprenorphine services by population (Patient Capacity Rates)
• The need for treatment services for opioid misuse and abuse (High-Need Counties)
• The availability of office-based buprenorphine services in counties with high needs for treatment services (High-Need Counties’ Patient Capacity)

The table below the map provides county-by-county data for the number of waivered providers and county patient capacity rates as of April 2018. A full analysis and explanation of the data in the map and table can be found in OIG’s report, Geographic Disparities Affect Access to Buprenorphine Services for Opioid Use Disorder, OEI-12-17-00240.

Physicians and certain other qualified providers who obtain a waiver from the Substance Abuse and Mental Health Services Administration are allowed to prescribe buprenorphine to patients in office settings (e.g., primary care practices, community health centers, treatment centers) to treat opioid use disorder. For the most recent waivered provider information in each county, please refer to SAMHSA’s Buprenorphine Practitioner Locator.

Rates of Patient Capacity and OUD Treatment Need in the United States by County, 2018

NOTE: Alaska and Hawaii are not displayed on this map. To obtain county-level data in these States, please refer to the table below.

Table: Rates of Patient Capacity and OUD Treatment Need in the United States by County, 2018

Counties highlighted in red below were classified by OIG as having a high need for treatment services.

This data was extracted from OIG’s full report, OEI-12-17-00240, OIG HHS.